Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far?

Table 9

Overall survival and overall survival rates by therapeutic modality, adapted from Rusthoven et al. (2016) [17].

	OS (months)	3-year OS rate (%)	5-year OS rate (%)	8-year OS rate (%)
RT + ADT	53	62,0	49,0	33,0
ADT	29	43,0	25,0	13,0

OS: overall survival; RT: radiotherapy; ADT: androgen deprivation therapy.